Michael Lauck

Michael Lauck is a Senior Research Scientist 2 at Promega Corporation, with a tenure beginning in October 2015 and progressing from Senior Research Scientist 1. Prior experience includes serving as an Assistant Scientist at the University of Wisconsin-Madison from January 2010 to October 2015, where notable contributions involved establishing pipelines for virus discovery, leading microbiome projects, validating clinical pathogen identification, mentoring graduate students, and managing research timelines and budgets. Michael's academic background includes a PhD in Cellular and Molecular Biology from the University of Wisconsin-Madison and previous research at the Robert Koch Institute, focusing on the immunosuppressive properties of HIV-1 gp41. Additionally, education encompasses Diplom degrees in Virology and Microbiology from the University of Tübingen and the Robert Koch Institute.